Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Diminishing dry weight is strongly associated with all-cause mortality among long-term maintenance prevalent dialysis patients.

Sato Y, Toida T, Nakagawa H, Iwakiri T, Nishizono R, Kikuchi M, Fujimoto S.

PLoS One. 2018 Aug 27;13(8):e0203060. doi: 10.1371/journal.pone.0203060. eCollection 2018.

2.

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer.

Fukuda M, Okumura M, Iwakiri T, Arimori K, Honda T, Kobayashi K, Senju H, Takemoto S, Ikeda T, Yamaguchi H, Nakatomi K, Matsuo N, Mukae H, Ashizawa K.

Thorac Cancer. 2018 Jan;9(1):51-58. doi: 10.1111/1759-7714.12535. Epub 2017 Oct 20.

3.

Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.

Uchino H, Fujishima J, Fukuoka K, Iwakiri T, Kamikuri A, Maeda H, Nakama K.

J Toxicol Sci. 2017;42(5):629-640. doi: 10.2131/jts.42.629.

4.

Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.

Fukuda A, Minakawa A, Sato Y, Iwakiri T, Iwatsubo S, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1818-1830. doi: 10.1093/ndt/gfx047.

5.

Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.

Matsuura Y, Yamashita A, Zhao Y, Iwakiri T, Yamasaki K, Sugita C, Koshimoto C, Kitamura K, Kawai K, Tamaki N, Zhao S, Kuge Y, Asada Y.

PLoS One. 2017 Apr 14;12(4):e0175976. doi: 10.1371/journal.pone.0175976. eCollection 2017.

6.

Asymptomatic Plaques of Lower Peripheral Arteries and Their Association with Cardiovascular Disease: An Autopsy Study.

Nakamura E, Sato Y, Iwakiri T, Yamashita A, Moriguchi-Goto S, Maekawa K, Gi T, Asada Y.

J Atheroscler Thromb. 2017 Sep 1;24(9):921-927. doi: 10.5551/jat.39669. Epub 2017 Mar 31.

7.

Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study.

Toida T, Iwakiri T, Sato Y, Komatsu H, Kitamura K, Fujimoto S.

PLoS One. 2017 Jan 3;12(1):e0169117. doi: 10.1371/journal.pone.0169117. eCollection 2017.

8.

Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.

Sato Y, Fujimoto S, Toida T, Nakagawa H, Yamashita Y, Iwakiri T, Fukuda A, Iwatsubo S.

Clin J Am Soc Nephrol. 2016 May 6;11(5):840-6. doi: 10.2215/CJN.09830915. Epub 2016 Feb 15.

9.

Paragonimiasis Due to the Consumption of Wild Boar Meat in Japan: Contamination Levels of Lung Fluke Larvae in Muscle Samples of Wild Boars Caught in Kagoshima Prefecture.

Sugiyama H, Shibata K, Kawakami Y, Arakawa K, Morishima Y, Yamasaki H, Gokuden M, Iwakiri T, Fukumori J.

Jpn J Infect Dis. 2015;68(6):536-7. doi: 10.7883/yoken.JJID.2015.280. Epub 2015 Sep 11. No abstract available.

10.

Human coronary thrombus formation is associated with degree of plaque disruption and expression of tissue factor and hexokinase II.

Okuyama N, Matsuda S, Yamashita A, Moriguchi-Goto S, Sameshima N, Iwakiri T, Matsuura Y, Sato Y, Asada Y.

Circ J. 2015;79(11):2430-8. doi: 10.1253/circj.CJ-15-0394. Epub 2015 Sep 3.

11.

Urine podocyte mRNAs mark disease activity in IgA nephropathy.

Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.

Nephrol Dial Transplant. 2015 Jul;30(7):1140-50. doi: 10.1093/ndt/gfv104. Epub 2015 May 8.

12.

Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.

Matsuura Y, Yamashita A, Iwakiri T, Sugita C, Okuyama N, Kitamura K, Asada Y.

Thromb Haemost. 2015 Jul;114(1):158-72. doi: 10.1160/TH14-09-0794. Epub 2015 Apr 2.

PMID:
25833755
13.

[Clinical characteristics of patients with IgA nephropathy and long-term survival after dialysis therapy].

Komatsu H, Nakagawa H, Iwakiri T, Toida T, Fukuda A, Kikuchi M, Sato Y, Kitamura K, Fujimoto S.

Nihon Jinzo Gakkai Shi. 2014;56(8):1251-9. Japanese.

PMID:
25551986
14.

Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.

Yamashita A, Zhao Y, Matsuura Y, Yamasaki K, Moriguchi-Goto S, Sugita C, Iwakiri T, Okuyama N, Koshimoto C, Kawai K, Tamaki N, Zhao S, Kuge Y, Asada Y.

PLoS One. 2014 Jan 23;9(1):e86426. doi: 10.1371/journal.pone.0086426. eCollection 2014.

15.

Long-term survival of patients with IgA nephropathy after dialysis therapy.

Komatsu H, Kikuchi M, Nakagawa H, Fukuda A, Iwakiri T, Toida T, Sato Y, Kitamura K, Fujimoto S.

Kidney Blood Press Res. 2013;37(6):649-56. doi: 10.1159/000355745. Epub 2013 Dec 14.

16.

Association between renal vasculature changes and generalized atherosclerosis: an autopsy survey.

Iwakiri T, Sato Y, Matsuura Y, Hatakeyama K, Marutsuka K, Yamashita A, Fujimoto S, Kitamura K, Asada Y.

J Atheroscler Thromb. 2014;21(2):99-107. Epub 2013 Oct 5.

17.

Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions.

Yamashita A, Zhao Y, Zhao S, Matsuura Y, Sugita C, Iwakiri T, Okuyama N, Ohe K, Koshimoto C, Kawai K, Tamaki N, Kuge Y, Asada Y.

Circ J. 2013;77(10):2626-35. Epub 2013 Jul 6.

18.

Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Iwakiri T, Fujimoto S, Kitagawa K, Furuichi K, Yamahana J, Matsuura Y, Yamashita A, Uezono S, Shimao Y, Hisanaga S, Tokura T, Wada T, Kitamura K, Asada Y.

BMC Nephrol. 2013 Jun 17;14:125. doi: 10.1186/1471-2369-14-125.

19.

Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor.

Sugita C, Yamashita A, Matsuura Y, Iwakiri T, Okuyama N, Matsuda S, Matsumoto T, Inoue O, Harada A, Kitazawa T, Hattori K, Shima M, Asada Y.

Thromb Haemost. 2013 Jul;110(1):62-75. doi: 10.1160/TH13-01-0069. Epub 2013 May 2.

PMID:
23636277
20.

Synthesis of 3,5,3',4'-tetrahydroxy-trans-stilbene-4'-O-beta-D-glucopyranoside by glucosyltransferases from Phytolacca americana.

Iwakiri T, Imai H, Hamada H, Nakayama T, Ozaki S.

Nat Prod Commun. 2013 Jan;8(1):119-20.

PMID:
23472474
21.

Associations of intrauterine growth restriction with placental pathological factors, maternal factors and fetal factors; clinicopathological findings of 257 Japanese cases.

Sato Y, Benirschke K, Marutsuka K, Yano Y, Hatakeyama K, Iwakiri T, Yamada N, Kodama Y, Sameshima H, Ikenoue T, Asada Y.

Histol Histopathol. 2013 Jan;28(1):127-32. doi: 10.14670/HH-28.127.

PMID:
23233065
22.

The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma.

Yamashita J, Iwakiri T, Fukushima S, Jinnin M, Miyashita A, Hamasaki T, Makino T, Aoi J, Masuguchi S, Inoue Y, Ihn H.

Melanoma Res. 2013 Feb;23(1):13-20. doi: 10.1097/CMR.0b013e32835c5b30.

PMID:
23222547
23.

Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis.

Iwakiri T, Yano Y, Sato Y, Hatakeyama K, Marutsuka K, Fujimoto S, Kitamura K, Kario K, Asada Y.

Atherosclerosis. 2012 Dec;225(2):359-62. doi: 10.1016/j.atherosclerosis.2012.10.033. Epub 2012 Oct 12.

PMID:
23092826
24.

Post-embolisation susceptibility changes in giant meningiomas: multiparametric histogram analysis using non-contrast-enhanced susceptibility-weighted PRESTO, diffusion-weighted and perfusion-weighted imaging.

Nishiguchi T, Iwakiri T, Hayasaki K, Ohsawa M, Yoneda T, Mitsuhashi Y, Nishio A, Dousset V, Miki Y.

Eur Radiol. 2013 Feb;23(2):551-61. doi: 10.1007/s00330-012-2618-8. Epub 2012 Sep 26.

PMID:
23011211
25.

Thrombus components in cardioembolic and atherothrombotic strokes.

Sato Y, Ishibashi-Ueda H, Iwakiri T, Ikeda Y, Matsuyama T, Hatakeyama K, Asada Y.

Thromb Res. 2012 Aug;130(2):278-80. doi: 10.1016/j.thromres.2012.04.008. Epub 2012 Apr 28. No abstract available.

PMID:
22542364
26.

Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.

Kawano Y, Nagata M, Kohno T, Ichimiya A, Iwakiri T, Okumura M, Arimori K.

Biol Pharm Bull. 2012;35(3):400-7.

27.

A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.

Yamashita S, Ryu S, Miyata S, Uchinokura S, Yokogami K, Uehara H, Moriguchi S, Iwakiri T, Marutsuka K, Ikenoue M, Sawa D, Yamada N, Kodama Y, Takeshima H.

Brain Tumor Pathol. 2012 Apr;29(2):107-12. doi: 10.1007/s10014-011-0071-z. Epub 2011 Dec 3.

PMID:
22139530
28.

Regioselective glucosidation of trans-resveratrol in Escherichia coli expressing glucosyltransferase from Phytolacca americana.

Ozaki S, Imai H, Iwakiri T, Sato T, Shimoda K, Nakayama T, Hamada H.

Biotechnol Lett. 2012 Mar;34(3):475-81. doi: 10.1007/s10529-011-0784-4. Epub 2011 Nov 3.

29.

Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.

Okumura M, Iwakiri T, Takagi A, Hirabara Y, Kawano Y, Arimori K.

Biochem Pharmacol. 2011 Dec 1;82(11):1720-30. doi: 10.1016/j.bcp.2011.07.095. Epub 2011 Aug 5.

PMID:
21840303
30.

Transcriptional up-regulation of cell surface Na V 1.7 sodium channels by insulin-like growth factor-1 via inhibition of glycogen synthase kinase-3β in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.

Yanagita T, Satoh S, Uezono Y, Matsuo K, Nemoto T, Maruta T, Yoshikawa N, Iwakiri T, Minami K, Murakami M.

Neuropharmacology. 2011 Dec;61(8):1265-74. doi: 10.1016/j.neuropharm.2011.07.029. Epub 2011 Jul 28.

PMID:
21816165
31.

Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.

Nagata M, Hidaka Y, Hatakeyama K, Kawano Y, Iwakiri T, Okumura M, Arimori K.

Biopharm Drug Dispos. 2011 Mar;32(2):126-30. doi: 10.1002/bdd.744. Epub 2010 Dec 28.

PMID:
21341281
32.

Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits.

Matsuda S, Yamashita A, Sato Y, Kitajima S, Koike T, Sugita C, Moriguchi-Goto S, Hatakeyama K, Takahashi M, Koshimoto C, Matsuura Y, Iwakiri T, Chen YE, Fan J, Asada Y.

J Thromb Haemost. 2011 Jan;9(1):201-8. doi: 10.1111/j.1538-7836.2010.04086.x.

33.

Effect of acute hepatic failure on the hepatic first-pass effect of 5-fluorouracil in rats.

Nagata M, Hidaka Y, Hidaka M, Kawano Y, Iwakiri T, Okumura M, Arimori K.

J Pharm Pharmacol. 2010 May;62(5):598-603. doi: 10.1211/jpp/62.05.0006.

PMID:
20609061
34.

Hepatocyte growth factor increases uptake of estradiol 17beta-D-glucuronide and Oatp1 protein level in rat hepatocytes.

Iwakiri T, Okumura M, Matsunaga N, Ichihara E, Shiotsuki S, Nagata M, Kumagai Y, Kai H, Arimori K.

Eur J Pharmacol. 2008 Feb 2;580(1-2):19-26. Epub 2007 Oct 25.

PMID:
18031729
35.

Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes.

Iwakiri T, Okumura M, Hidaka M, Kumagai Y, Ichihara E, Kawano Y, Arimori K.

J Appl Toxicol. 2008 Apr;28(3):329-36.

PMID:
17604344
36.

Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea.

Hidaka M, Yamasaki K, Okumura M, Ogikubo T, Iwakiri T, Setoguchi N, Nishida K, Nagai K, Ikenoue T, Arimori K.

Cancer Chemother Pharmacol. 2007 Feb;59(3):321-8. Epub 2006 Jun 13.

PMID:
16770581
37.

Transient inhibition of cyp3a in rats by star fruit juice.

Hidaka M, Okumura M, Ogikubo T, Kai H, Fujita K, Iwakiri T, Yamasaki K, Setoguchi N, Matsunaga N, Arimori K.

Drug Metab Dispos. 2006 Mar;34(3):343-5. Epub 2005 Dec 2.

PMID:
16326816
38.

Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro.

Yamasaki K, Kuga N, Takamura N, Furuya Y, Hidaka M, Iwakiri T, Nishii R, Okumura M, Kodama H, Kawai K, Arimori K.

Biol Pharm Bull. 2005 Mar;28(3):549-52.

39.

Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.

Hidaka M, Okumura M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Setoguchi N, Arimori K.

Drug Metab Dispos. 2005 May;33(5):644-8. Epub 2005 Jan 26.

PMID:
15673597
40.

Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity.

Hidaka M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Okumura M, Kodama H, Arimori K.

Drug Metab Dispos. 2004 Jun;32(6):581-3.

PMID:
15155547
41.

Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans.

Fujita K, Hidaka M, Takamura N, Yamasaki K, Iwakiri T, Okumura M, Kodama H, Yamaguchi M, Ikenoue T, Arimori K.

Biol Pharm Bull. 2003 Sep;26(9):1371-3.

42.

Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.

Arimori K, Kuroki N, Hidaka M, Iwakiri T, Yamsaki K, Okumura M, Ono H, Takamura N, Kikuchi M, Nakano M.

Pharm Res. 2003 Jun;20(6):910-7.

PMID:
12817897
43.

Adrenomedullin increases phosphatidylcholine secretion in rat type II pneumocytes.

Okumura M, Kai H, Arimori K, Iwakiri T, Hidaka M, Shiramoto S, Isohama Y, Miyata T.

Eur J Pharmacol. 2000 Sep 8;403(3):189-94.

PMID:
10973618
44.

[Prevalence of diabetic ocular complications and systemic factors].

Funatsu H, Suto C, Hori S, Kitamura Y, Iwakiri T, Iwasaki M, Totani R, Kato S.

Nippon Ganka Gakkai Zasshi. 1993 Aug;97(8):947-54. Japanese.

PMID:
8368183
45.

[A case of lung cancer producing CA19-9 and amylase].

Takano Y, Iwakiri T, Ichiyasu Y.

Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Feb;31(2):267-70. Japanese.

PMID:
7685838
46.

[A case of bucillamine-induced interstitial pneumonia].

Hara A, Sakamoto O, Matsumoto M, Sakata T, Kohrogi H, Sugimoto M, Ando M, Araki S, Iwakiri T.

Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Sep;30(9):1743-8. Japanese.

PMID:
1447852
47.

Studies on the isotetracenone antibiotics. III. A new isotetracenone antibiotic, grincamycin.

Hayakawa Y, Iwakiri T, Imamura K, Seto H, Otake N.

J Antibiot (Tokyo). 1987 Dec;40(12):1785-7. No abstract available.

48.

Juglorin, a new spermidine synthase inhibitor.

Hamaguchi K, Iwakiri T, Imamura K, Furihata K, Seto H, Otake N.

J Antibiot (Tokyo). 1987 May;40(5):717-9. No abstract available.

49.

Studies on the isotetracenone antibiotics. II. Kerriamycins A, B and C, new antitumor antibiotics.

Hayakawa Y, Iwakiri T, Imamura K, Seto H, Otake N.

J Antibiot (Tokyo). 1985 Jul;38(7):960-3. No abstract available.

50.

Studies on the isotetracenone antibiotics. I. Capoamycin, a new antitumor antibiotic.

Hayakawa Y, Iwakiri T, Imamura K, Seto H, Otake N.

J Antibiot (Tokyo). 1985 Jul;38(7):957-9. No abstract available.

Supplemental Content

Loading ...
Support Center